Ownership of Regulatory Documentation. All Regulatory Approvals with respect to the Product will be owned by OncoGenex for the duration of the Collaboration. If the Collaboration terminates, or if one Party discontinues performance according to the terms of this Agreement, all Regulatory Approvals will remain with the Party that has retained the rights to the Product.
Appears in 3 contracts
Sources: Collaboration and Co Development Agreement (Oncogenex Technologies Inc), Collaboration and Co Development Agreement (Isis Pharmaceuticals Inc), Collaboration and Co Development Agreement (Oncogenex Technologies Inc)